Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Cash & Equivalents: 2020-2024

Historic Cash & Equivalents for DocGo (DCGO) over the last 5 years, with FY2024 value amounting to $89.2 million.

  • DocGo's Cash & Equivalents fell 1800.03% to $73.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.4 million, marking a year-over-year decrease of 1800.03%. This contributed to the annual value of $89.2 million for FY2024, which is 5052.71% up from last year.
  • According to the latest figures from FY2024, DocGo's Cash & Equivalents is $89.2 million, which was up 5052.71% from $59.3 million recorded in FY2023.
  • DocGo's Cash & Equivalents' 5-year high stood at $175.5 million during FY2021, with a 5-year trough of $32.4 million in FY2020.
  • For the 5-year period, DocGo's Cash & Equivalents averaged around $102.8 million, with its median value being $89.2 million (2024).
  • Per our database at Business Quant, DocGo's Cash & Equivalents surged by 44147.7% in 2021 and then plummeted by 6231.86% in 2023.
  • Over the past 5 years, DocGo's Cash & Equivalents (Annual) stood at $32.4 million in 2020, then surged by 441.48% to $175.5 million in 2021, then fell by 10.37% to $157.3 million in 2022, then crashed by 62.32% to $59.3 million in 2023, then surged by 50.53% to $89.2 million in 2024.
  • Its Cash & Equivalents stands at $89.2 million for FY2024, versus $59.3 million for FY2023 and $157.3 million for FY2022.